The present invention relates to novel 2,3-diamino-quinazolinone derivatives having medical utility, to use of the derivatives for the manufacture of a medicament, to pharmaceutical compositions comprising the derivatives, and to methods of treating a disorder, disease or a condition responsive to activation of Kv7 channels.
本发明涉及具有医学用途的新型2,3-二
氨基
喹唑啉酮衍
生物,用于制造药物的衍
生物的使用,包括该衍
生物的制药组合物,以及治疗对Kv7通道激活有反应的疾病、疾病或病症的方法。